{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:09:12Z","timestamp":1791403752430,"version":"4.3.3"},"reference-count":34,"publisher":"Termedia Sp. z.o.o.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatologia"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Antiphospholipid syndrome (APS) manifests with thrombosis and pregnancy losses and may significantly impair the health-related quality of life (HRQoL). So far, APS has been perceived as a less burdensome disease than systemic lupus erythematosus (SLE), but data on this are scarce. The purpose of the present study was to evaluate HRQoL in APS patients by applying the Short Form 36 Health Survey (SF-36) and World Health Organization Quality-of-Life Scale (WHOQoL-BREF); to examine the impact of primary APS and with coexisting SLE (APS\/SLE) on patient HRQoL; and to provide a description of the APS patient population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>One hundred twelve patients with APS were included in the study, 57 of them with primary APS and 55 with coexisting SLE. HRQoL was measured by the 36-Item SF-36 and WHOQoL questionnaires.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean age was 47 years (47.6 \u00b113.8), and 96 patients were (85.7%) women. The mean disease duration was 72 months. Health-related quality of life impairment was found in both components for all APS patients in comparison to the healthy Polish population (&lt;i&gt;p&lt;\/i&gt; &lt; 0.0001). There was no diffe\u00adrence between APS and APS\/SLE groups in HRQoL (mental component &lt;i&gt;p&lt;\/i&gt; = 1.0, physical component &lt;i&gt;p&lt;\/i&gt; = 0.337). The history of venous thrombosis was associated with HRQoL impairment only in the APS\/SLE group in the physical component (&lt;i&gt;p&lt;\/i&gt; = 0.0118), not in primary APS (&lt;i&gt;p&lt;\/i&gt; = 0.6862). The mental component of SF-36 was associated with all domains of WHOQoL-BREF, while the physical component was associated only with physical health (&lt;i&gt;p&lt;\/i&gt; &lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Primary APS and APS secondary to SLE lead to equal impairment in HRQoL. Diagnosis and proper management of all patients with APS are essential to prevent thrombosis and miscarriages, which ultimately will lead to longer survival with optimal life quality.<\/jats:p><\/jats:sec>","DOI":"10.5114\/reum\/192028","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:52:23Z","timestamp":1726487543000},"page":"266-273","source":"Crossref","is-referenced-by-count":2,"title":["Health-related quality of life impairment is equal for antiphospholipid syndrome whether primary or associated with systemic lupus erythematosus"],"prefix":"10.5114","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5677-6292","authenticated-orcid":true,"given":"Ewa","family":"Haladyj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Matusiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wysocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Olesinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"ref-1252091","doi-asserted-by":"crossref","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295\u2013306.","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"ref-1252092","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.79.928.81"},{"key":"ref-1252093","doi-asserted-by":"crossref","unstructured":"Kahn SR, Hirsch A, Shrier I. Effect of post-thrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162: 1144\u20131148, DOI: 10.1001\/ archinte.162.10.1144..","DOI":"10.1001\/archinte.162.10.1144"},{"key":"ref-1252094","doi-asserted-by":"crossref","unstructured":"Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6: 1105\u20131112, DOI: 10.1111\/ j.1538-7836.2008.03002.x.","DOI":"10.1111\/j.1538-7836.2008.03002.x"},{"key":"ref-1252095","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-10-0640"},{"key":"ref-1252096","doi-asserted-by":"publisher","DOI":"10.5505\/agri.2015.38278"},{"key":"ref-1252097","unstructured":"Madureira S, Canh\u00e3o P, Ferro JM. Cognitive and behavioural outcome of patients with cerebral venous thrombosis. Cerebrovasc Dis 2001; 11: 108."},{"key":"ref-1252098","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622\u2013629, DOI: 10.7326\/ 0003-4819-118-8-199304150-00009.","DOI":"10.7326\/0003-4819-118-8-199304150-00009"},{"key":"ref-1252099","doi-asserted-by":"publisher","DOI":"10.1177\/0961203306071710"},{"key":"ref-1252100","doi-asserted-by":"publisher","DOI":"10.1191\/0961203304lu1083rr"},{"key":"ref-1252101","doi-asserted-by":"crossref","unstructured":"Hughes GRV. Hughes syndrome: A patient\u2019s guide. Springer- Verlag, London 2001.","DOI":"10.1007\/978-1-4471-0323-3"},{"key":"ref-1252102","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187"},{"key":"ref-1252103","unstructured":"Strand V, Singh JA. Improved Health related Quality of Life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care 2007 Suppl 9: S237\u2013S251."},{"key":"ref-1252104","unstructured":"Boers M, Brooks P, Strand V, et al. The OMERACT filter for outcomes measures in rheumatology. J Rheumatol 1998; 25: 198\u2013199."},{"key":"ref-1252105","doi-asserted-by":"publisher","DOI":"10.1136\/ard"},{"key":"ref-1252106","doi-asserted-by":"crossref","unstructured":"Ware JE. SF-36 health survey update. Lincoln: Quality- Metric Incorporated; Spine 2000; 25: 3130\u20133139, DOI: 10.1097\/ 00007632-200012150-00008.","DOI":"10.1097\/00007632-200012150-00008"},{"key":"ref-1252107","unstructured":"Ciconelli RF, Santos MR, Meiraos I. Translation into Portuguese and validation of the generic questionnaire for assessing quality of life SF-36 Brazil SF-36. Rev Bras Reumatol 1999; 39: 143\u2013150."},{"key":"ref-1252108","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199303000-00006"},{"key":"ref-1252109","doi-asserted-by":"publisher","DOI":"10.1007\/BF00435734"},{"key":"ref-1252110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098883"},{"key":"ref-1252111","unstructured":"Wang C, Mayo N, Fortin P. The relationship between related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001; 28; 3: 525\u2013532."},{"key":"ref-1252112","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312456749"},{"key":"ref-1252113","doi-asserted-by":"crossref","unstructured":"Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus an update. Ann Acad Med Singap 2007; 36: 115\u2013122.","DOI":"10.47102\/annals-acadmedsg.V36N2p115"},{"key":"ref-1252114","doi-asserted-by":"crossref","unstructured":"Bazzan M, Vaccarino A, Marletto F. Systemic lupus erythematosus and thrombosis. Thromb J 2015; 13: 16.","DOI":"10.1186\/s12959-015-0043-3"},{"key":"ref-1252115","doi-asserted-by":"crossref","unstructured":"Zuily S, Rat AC, Regnault V, et al.; TAC(I)T investigators. Impairment of quality of life in patients with antiphospholipid syndrome. Lupus 2015; 24: 1161\u20131168, DOI: 10.1177\/ 0961203315580871.","DOI":"10.1177\/0961203315580871"},{"key":"ref-1252116","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314551809"},{"key":"ref-1252117","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13045"},{"key":"ref-1252118","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101054"},{"key":"ref-1252119","unstructured":"Hopman WM, Towheed T, Anastassiades T, et al. Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ 2000; 163: 265\u2013271."},{"key":"ref-1252120","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/22.2.167"},{"key":"ref-1252121","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.04.007"},{"key":"ref-1252122","doi-asserted-by":"crossref","unstructured":"Huang I-C, Wu AW, Frangakis C. Do the SF-36 and WHOQOL-BREF measure the same constructs? Evidence from the Taiwan population. Qual Life Res 2006; 15: 15\u201324, DOI: 10.1007\/ s11136-005-8486-9.","DOI":"10.1007\/s11136-005-8486-9"},{"key":"ref-1252123","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-6252-z"},{"key":"ref-1252124","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S258953"}],"container-title":["Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/reu.termedia.pl\/pdf-192028-114066","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reu.termedia.pl\/pdf-192028-114066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:52:46Z","timestamp":1726487566000},"score":1,"resource":{"primary":{"URL":"https:\/\/reu.termedia.pl\/Health-related-quality-of-life-impairment-is-equal-for-antiphospholipid-syndrome,192028,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"alternative-id":["192028"],"URL":"https:\/\/doi.org\/10.5114\/reum\/192028","relation":{},"ISSN":["0034-6233","2084-9834"],"issn-type":[{"value":"0034-6233","type":"print"},{"value":"2084-9834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]}}}